Navigation Links
DePuy Recalled Hip Device Lawsuit Filed in East Texas
Date:3/18/2011

TYLER, Texas, March 18, 2011 /PRNewswire/ -- Richard Dykes filed suit today against Johnson & Johnson, Inc. and DePuy Orthopaedics, Inc. seeking compensation for injuries caused by the failure of the DePuy ASR XL Acetabular Hip Replacement System that has been recalled.  John David Hart of the Law Offices of John David Hart in Fort Worth, Texas, is the attorney representing Mr. Dykes in the suit filed in the United States District Court for the Eastern District of Texas in Tyler, Texas.

On or about December 5, 2008, Mr. Dykes underwent hip replacement surgery and received an ASR XL Acetabular system with an AML femoral stem implanted in his left hip. Since the surgical implantation of the ASR XL Acetabular System in his left hip, Mr. Dykes has suffered symptoms including, but not limited to severe pain, problems sitting and standing, elevated levels of metal ions in his blood, and possible loosening.  Due to these complications, he may require a revision surgery in the future.

"The DePuy ASR XL Acetabular Hip Replacement System has an unacceptable failure rate of more than one out of every eight," said attorney John David Hart.  "One of those who was injured by this dangerous product was Richard Dykes.  Now, he lives with pain every day and is facing the potential for revision surgery.  Medical devices like the ASR XL Acetabular Hip Replacement System must be safe and effective for the health of every patient."

DePuy Orthopaedics, Inc., a division of Johnson and Johnson, Inc., recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. This recall came after data from a recent study indicated that the five year failure rate of this product is approximately 13%, or more than 1 out of every 8 patients. DePuy identified reasons for the failure of the hip replacement system as component loosening, component malalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications from the DePuy ASR XL Acetabular hip replacement system may include increased metal ion levels in the blood, bone staining, necrosis, swelling, nerve damage, tissue damage and/or muscle damage. This device was marketed by DePuy Orthopaedics as a high performance hip replacement system.

John David Hart and the Law Offices of John David Hart represent many individuals in the United States who have been injured as a result of this defective hip replacement system.  The Law Offices of John David Hart is a group of experienced and dedicated legal professionals working to protect the rights of people wronged by the acts of others.  Across the country, the firm represents individuals in cases of catastrophic personal injury, wrongful death, dangerous drugs, automobile and truck accidents and oil and gas litigation. For more information, please contact John Hart at 800.961.4278 or johnhart@hartlaw.com.


'/>"/>
SOURCE The Law Offices of John David Hart
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device
2. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
3. Rottenstein Law Group Applauds New Efforts of U.S. FDA to Look More Carefully at Metal-on-Metal Implants After DePuy Recall
4. Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
5. Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc.
6. Chesley Files Class Action Against DePuy Orthopaedics
7. Federal Panel Grants Lanier Law Firm Motion for Hearing on National Coordination of DePuy Hip Implant Lawsuits
8. DePuy Orthopaedics Accused of Deceiving Hip Replacement Patients
9. DePuy Hip Recall & Avandia Focus of Nov. 3 Conference, HB Announces
10. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
11. DePuy Orthopaedics Voluntarily Recalls ASR™ Hip System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):